Sanford & Sons strategically invested in Jules's health supplement company, realizing significant growth and a successful exit in September 2020.
Information on the Target
The target of this investment is a health supplement company led by founder Jules, who was introduced to the investors through another portfolio company. Recognizing Jules's dedication and hard work, the investors were motivated to provide capital support aimed at expanding the company's product range.
As the business rapidly gained traction in the health supplement market, the investors made the strategic decision to take a significant 50% stake in the company, watching with satisfaction as Jules's vision transformed into a growing enterprise that continues to thrive.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The health supplement industry has experienced robust growth in recent years, reflecting a rising consumer awareness of health and wellness. Driven by
Similar Deals
Sanford & Sons
invested in
Jules
in 2020
in a Other VC deal